US Patent Issued to Debiopharm International on Sept. 16 for "Medicament and use thereof for treating bacterial infections involving biofilm" (Swiss, French Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,958, issued on Sept. 16, was assigned to Debiopharm International S.A. (Lausanne, Switzerland).

"Medicament and use thereof for treating bacterial infections involving biofilm" was invented by Justyna Nowakowska (Sion, Switzerland), Linda Kadi (Segny, France) and Gregoire Vuagniaux (Lausanne, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of Afabicin in a method of treating bacterial infections involving biofilm that contains staphylococcus bacteria, wherein the method comprises administering Afabicin in combination with at least one further agent selected from lipopeptides, glycopeptides and lin...